Background Nigeria has the tenth highest burden of tuberculosis (TB) among the 22 TB high-burden countries in the world. This study describes the biodiversity and epidemiology of drug-susceptible and drug-resistant TB in Ibadan, Nnewi and Abuja, using 409 DNAs extracted from culture positive TB isolates. Methodology/Principal Findings DNAs extracted from clinical isolates of Mycobacterium tuberculosis complex were studied by spoligotyping and 24 VNTR typing. The Cameroon clade (CAM) was predominant followed by the M. africanum (West African 1) and T (mainly T2) clades. By using a smooth definition of clusters, 32 likely epi-linked clusters related to the Cameroon genotype family and 15 likely epi-linked clusters related to other “modern” genotypes were detected. Eight clusters concerned M. africanum West African 1. The recent transmission rate of TB was 38%. This large study shows that the recent transmission of TB in Nigeria is high, without major regional differences, with MDR-TB clusters. Improvement in the TB control programme is imperative to address the TB control problem in Nigeria.
References
[1]
Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, et al. (2009) Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 373: 1861–1873.
[2]
Lawson L, Yassin MA, Abdurrahman ST, Parry CM, Dacombe R, et al. (2011) Resistance to first-line tuberculosis drugs in three cities of Nigeria. Trop Med Int Health.
[3]
Ani A, Bruvik T, Okoh Y, Agaba P, Agbaji O, et al. (2010) Genetic diversity of Mycobacterium tuberculosis Complex in Jos, Nigeria. BMC Infect Dis 10: 189.
[4]
Thumamo BP, Asuquo AE, Abia-Bassey LN, Lawson L, Hill V, et al. (2011) Molecular epidemiology and genetic diversity of Mycobacterium tuberculosis complex in the Cross River State, Nigeria. Infect Genet Evol.
[5]
Jenkins AO, Cadmus SI, Venter EH, Pourcel C, Hauk Y, et al. (2011) Molecular epidemiology of human and animal tuberculosis in Ibadan, Southwestern Nigeria. Vet Microbiol 151: 139–147.
[6]
Cadmus S, Hill V, van Soolingen D, Rastogi N (2011) Spoligotype profile of Mycobacterium tuberculosis complex strains from HIV-positive and -negative patients in Nigeria: a comparative analysis. J Clin Microbiol 49: 220–226.
[7]
Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, et al. (2008) Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis 12: 99–104.
[8]
Streicher EM, Muller B, Chihota V, Mlambo C, Tait M, et al. (2011) Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Infect Genet Evol.
[9]
Cowan LS, Diem L, Brake MC, Crawford JT (2004) Transfer of a Mycobacterium tuberculosis genotyping method, Spoligotyping, from a reverse line-blot hybridization, membrane-based assay to the Luminex multianalyte profiling system. J Clin Microbiol 42: 474–477.
[10]
Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, et al. (2006) Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing of Mycobacterium tuberculosis. J Clin Microbiol 44: 4498–4510.
[11]
Schurch AC, Kremer K, Daviena O, Kiers A, Boeree MJ, et al. (2010) High resolution typing by integration of genome sequencing data in a large tuberculosis cluster. J Clin Microbiol 48: 3403–3406.
[12]
Gardy JL, Johnston JC, Ho Sui SJ, Cook VJ, Shah L, et al. (2011) Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N Engl J Med 364: 730–739.
[13]
Cardoso Oelemann M, Gomes HM, Willery E, Possuelo L, Batista Lima KV, et al. (2011) The forest behind the tree: phylogenetic exploration of a dominant Mycobacterium tuberculosis strain lineage from a high tuberculosis burden country. PLoS One 6: e18256.
[14]
Yeboah-Manu D, Asante-Poku A, Bodmer T, Stucki D, Koram K, et al. (2011) Genotypic diversity and drug susceptibility patterns among M. tuberculosis complex isolates from South-Western Ghana. PLoS One 6: e21906.
[15]
Zhang J, Abadia E, Refregier G, Tafaj S, Boschiroli ML, et al. (2010) Mycobacterium tuberculosis complex CRISPR genotyping: improving efficiency, throughput and discriminative power of ‘spoligotyping’ with new spacers and a microbead-based hybridization assay. J Med Microbiol 59: 285–294.
[16]
Tafaj S, Zhang J, Hauck Y, Pourcel C, Hafizi H, et al. (2009) First insight into genetic diversity of the Mycobacterium tuberculosis complex in Albania obtained by multilocus variable-number tandem-repeat analysis and spoligotyping reveals the presence of beijing multidrug-resistant isolates. J Clin Microbiol 47: 1581–1584.
[17]
Brudey K, Driscoll J, Rigouts L, Prodinger WM, Gori A, et al. (2006) Mycobacterium tuberculosis complex genetic diversity : mining the fourth international spoligotyping database (SpolDB4) for classification, Population Genetics, and Epidemiology. BMC Microbiol 6: 23.
[18]
Demay C, Liens B, Burguière T, Hill V, Couvin D, et al. (2012) SITVITWEB – A publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. Infect Genet Evol Feb. 17 [Epub ahead of print].
[19]
Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, et al. (1994) The Epidemiology of Tuberculosis in San Francisco. N Engl J Med 330: 1703–1709.
[20]
Muller B, Hilty M, Berg S, Garcia-Pelayo MC, Dale J, et al. (2009) African 1, an epidemiologically important clonal complex of Mycobacterium bovis dominant in Mali, Nigeria, Cameroon, and Chad. J Bacteriol 191: 1951–1960.
[21]
Gagneux S, Small PM (2007) Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 7: 328–337.
[22]
Akhtar P, Singh S, Bifani P, Kaur S, Srivastava BS, et al. (2009) Variable-number tandem repeat 3690 polymorphism in Indian clinical isolates of Mycobacterium tuberculosis and its influence on transcription. J Med Microbiol 58: 798–805.
[23]
Frothingham R, Meeker-O’Connell WA (1998) Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats. Microbiology 144 (Pt 5): 1189–1196.
[24]
Abadia E, Zhang J, Vultos TD, Ritacco V, Kremer K, et al. (2010) Resolving lineage assignation on Mycobacterium tuberculosis clinical isolates classified by spoligotyping with a new high-throughput 3R SNPs based method. Infect Genet Evol 10 1066–1074.
[25]
Niobe-Eyangoh SN, Kuaban C, Sorlin P, Cunin P, Thonnon J, et al. (2003) Genetic biodiversity of Mycobacterium tuberculosis complex strains from patients with pulmonary tuberculosis in Cameroon. J Clin Microbiol 41: 2547–2553.
[26]
Niobe-Eyangoh SN, Kuaban C, Sorlin P, Thonnon J, Vincent V, et al. (2004) Molecular characteristics of strains of the cameroon family, the major group of Mycobacterium tuberculosis in a country with a high prevalence of tuberculosis. J Clin Microbiol 42: 5029–5035.
[27]
Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, et al. (1997) Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35: 907–914.
[28]
Sorek R, Kunin V, Hugenholtz P (2008) CRISPR–a widespread system that provides acquired resistance against phages in bacteria and archaea. Nat Rev Microbiol 6: 181–186.
[29]
Comas I, Homolka S, Niemann S, Gagneux S (2009) Genotyping of genetically monomorphic bacteria: DNA sequencing in mycobacterium tuberculosis highlights the limitations of current methodologies. PLoS One 4: e7815.
[30]
Kato-Maeda M, Gagneux S, Flores LL, Kim EY, Small PM, et al. (2011) Strain classification of Mycobacterium tuberculosis: congruence between large sequence polymorphisms and spoligotypes. Int J Tuberc Lung Dis 15: 131–133.
[31]
Fabre L, Zhang J, Guigon G, Le Hello S, Guibert V, et al. (2012) CRISPR typing and subtyping for improved laboratory surveillance of Salmonella infections. PloS One in Press.
[32]
Zhang J, Heng S, Le Moullec S, Refregier G, Gicquel B, et al. (2011) A first assessment of the genetic diversity of Mycobacterium tuberculosis complex in Cambodia. BMC Infect Dis 11: 42.
[33]
Murray M (2002) Determinants of cluster distribution in the molecular epidemiology of tuberculosis. Proc Natl Acad Sci U S A 99: 1538–1543.
[34]
Dos Vultos T, Mestre O, Rauzier J, Golec M, Rastogi N, et al. (2008) Evolution and Diversity of Clonal Bacteria: The Paradigm of Mycobacterium tuberculosis. PLoS ONE 3: e1538.
[35]
Diguimbaye C, Hilty M, Ngandolo R, Mahamat HH, Pfyffer GE, et al. (2006) Molecular characterization and drug resistance testing of Mycobacterium tuberculosis isolates from Chad. J Clin Microbiol 44: 1575–1577.
[36]
Godreuil S, Renaud F, Van de Perre P, Carriere C, Torrea G, et al. (2007) Genetic diversity and population structure of Mycobacterium tuberculosis in HIV-1-infected compared with uninfected individuals in Burkina Faso. Aids 21: 248–250.
[37]
Gomgnimbou MK, Refregier G, Diagbouga SP, Adama S, Kabore A, et al. (2012) Spoligotyping of Mycobacterium africanum, Burkina Faso. Emerg Infect Dis 18: 117–119.
[38]
de Jong BC, Antonio M, Awine T, Ogungbemi K, de Jong YP, et al. (2009) Use of spoligotyping and large-sequence polymorphisms to study the population structure of the Mycobacterium tuberculosis complex in a cohort study of consecutive smear positive tuberculosis cases in the Gambia. J Clin Microbiol.
[39]
Cadmus S, Palmer S, Okker M, Dale J, Gover K, et al. (2006) Molecular analysis of human and bovine tubercle bacilli from a local setting in Nigeria. J Clin Microbiol 44: 29–34.
[40]
Dos Vultos T, Mestre O, Tonjum T, Gicquel B (2009) DNA repair in Mycobacterium tuberculosis revisited. FEMS Microbiol Rev 33: 471–487.
[41]
Mestre O, Luo T, Dos Vultos T, Kremer K, Murray A, et al. (2011) Phylogeny of Mycobacterium tuberculosis Beijing strains constructed from polymorphisms in genes involved in DNA replication, recombination and repair. PLoS One 6: e16020.
